These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2237217)

  • 1. [Malignant strongyloidiasis and the HTLV-I virus].
    Neisson-Vernant C; Edouard A
    Rev Prat; 1990 Oct; 40(23):2127-8. PubMed ID: 2237217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
    Carvalho EM; Da Fonseca Porto A
    Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe and treatment resistant strongyloidiasis--indicator of HTLV-I infection.
    Jeyamani R; Joseph AJ; Chacko A
    Trop Gastroenterol; 2007; 28(4):176-7. PubMed ID: 18416349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area.
    Dixon AC; Yanagihara ET; Kwock DW; Nakamura JM
    West J Med; 1989 Oct; 151(4):410-3. PubMed ID: 2588581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human T-lymphotropic virus 1 (HTLV-1), strongyloidiasis and scabies. Infections and associations to considerate].
    Freites A
    Invest Clin; 2008 Dec; 49(4):455-6. PubMed ID: 19245164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological aspects of Strongyloides stercoralis infection in Okinawa, Japan.
    Arakaki T; Kohakura M; Asato R; Ikeshiro T; Nakamura S; Iwanaga M
    J Trop Med Hyg; 1992 Jun; 95(3):210-3. PubMed ID: 1597879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
    Einsiedel L; Fernandes L
    Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.
    Porto MA; Alcântara LM; Leal M; Castro N; Carvalho EM
    Am J Trop Med Hyg; 2005 Feb; 72(2):124-5. PubMed ID: 15741545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
    Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
    Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined infection with HTLV-1 and Strongyloides stercoralis].
    Pays JF
    Bull Soc Pathol Exot; 2011 Aug; 104(3):188-99. PubMed ID: 21800110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralis.
    Satoh M; Toma H; Sugahara K; Etoh K; Shiroma Y; Kiyuna S; Takara M; Matsuoka M; Yamaguchi K; Nakada K; Fujita K; Kojima S; Hori E; Tanaka Y; Kamihira S; Sato Y; Watanabe T
    Oncogene; 2002 Apr; 21(16):2466-75. PubMed ID: 11971181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic study of the association between human T-cell lymphotropic virus type 1 and Strongyloides stercoralis infection in female blood donors (Guadeloupe, French West Indies).
    Courouble G; Rouet F; Herrmann-Storck C; Nicolas M; Candolfi E; Deloumeaux J; Carme B
    West Indian Med J; 2004 Jan; 53(1):3-6. PubMed ID: 15114885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.
    Montes M; Sanchez C; Verdonck K; Lake JE; Gonzalez E; Lopez G; Terashima A; Nolan T; Lewis DE; Gotuzzo E; White AC
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e456. PubMed ID: 19513105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Strongyloides stercoralis hyperinfection syndrome with acute meningoencephalitis associated to HTLV-1 and HTLV-2 virus co-infection].
    N'dri K; Kouame KE; Sahari R; Hommel D; Hulin A
    Med Mal Infect; 2008 Mar; 38(3):162-4. PubMed ID: 18191522
    [No Abstract]   [Full Text] [Related]  

  • 15. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
    Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
    Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.
    Satoh M; Futami A; Takahira K; Kodaira M; Tanaka T; Kuriki K; Hori E
    J Infect Chemother; 2003 Dec; 9(4):355-7. PubMed ID: 14691660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
    Arch EL; Schaefer JT; Dahiya A
    Dermatol Online J; 2008 Dec; 14(12):6. PubMed ID: 19265619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enterococcal meningitis due to strongyloidiasis with HTLV-1 carrier].
    Sugiura A; Fujimoto M; Saida Y
    Rinsho Shinkeigaku; 2006 Oct; 46(10):715-7. PubMed ID: 17323782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duodenal obstruction due to
    Harshan M; Niyas VKM; Arjun R
    Trop Doct; 2022 Oct; 52(4):596-597. PubMed ID: 35833224
    [No Abstract]   [Full Text] [Related]  

  • 20. [Report of a case of strongyloidiasis with a coinfection by HTLV-1 and onychomycosis].
    Alvarez-Falconí PP; Moncada-Vilela Z; Montero-Navarrete S; Hernandez-García JA
    Rev Gastroenterol Peru; 2013; 33(4):348-51. PubMed ID: 24419034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.